Photoacoustic molecular imaging has gained popularity for its unique optical absorption contrast, high resolution, deep imaging capabilities, and speed. However, traditional methods have been limited by the strong optical attenuation in biological tissues, restricting penetration depth. To address this, various technologies have been developed, such as using longer-wavelength excitation light, deep-penetrating microwaves, and X-ray photons, as well as enhancing ultrasonic transducer sensitivity. Novel imaging systems, image processing methods, and molecular probes have been introduced to enhance deep photoacoustic (PA) molecular imaging, with a focus on overcoming existing challenges and exploring future directions.
Molecular imaging plays a vital role in understanding biological processes at the molecular level, impacting disease diagnosis, drug development, and therapy assessment. Various imaging modalities, including X-ray CT, MRI, ultrasound, optical imaging, and photoacoustic tomography (PAT), have been utilized for molecular imaging. PAT, a hybrid imaging technique combining optical and ultrasound imaging, offers high sensitivity to optical absorption contrast, making it suitable for functional and molecular imaging. Two primary implementations of PAT are photoacoustic microscopy (PAM) and photoacoustic computed tomography (PACT), each with distinct strengths in resolution and penetration depth. PACT, in particular, shows promise for clinical applications due to its deep imaging capabilities.
Despite its advantages, PAT faces challenges such as limited penetration depth compared to other imaging modalities and imaging artifacts. Efforts to address these challenges include optimizing excitation wavelengths, improving light delivery, and enhancing ultrasonic transducer sensitivity. Innovations like long-wavelength excitation light, wavefront shaping, and internal light illumination have shown promising results in enhancing penetration depth. Additionally, the use of X-ray photons in X-ray-induced acoustic imaging (XAI) has demonstrated superior penetration depth in tissues, albeit with concerns regarding ionizing radiation exposure.
Enhancing ultrasonic transducer sensitivity is crucial for improving the penetration depth of PAT. Techniques like capacitive micromachined ultrasonic transducers (CMUTs) and optical sensors offer advantages in sensitivity and bandwidth. These advancements in ultrasonic transducer fabrication and optical detection methods have shown significant improvements in detection sensitivity, leading to enhanced imaging performance in deep-seated tissues. Future advancements in PAT technology focus on increasing penetration depth, sensitivity, and resolution through innovative imaging systems, reconstruction algorithms, and contrast agents.
Key Takeaways:
– Photoacoustic molecular imaging offers unique capabilities for visualizing biological processes at the molecular level.
– Advancements in imaging technologies, such as longer-wavelength excitation light and wavefront shaping, enhance penetration depth in PAT.
– Techniques like capacitive micromachined ultrasonic transducers (CMUTs) and optical sensors improve ultrasonic transducer sensitivity for deeper tissue imaging.
– Future developments aim to further improve the penetration depth, sensitivity, and resolution of PAT for enhanced molecular imaging applications.
Tags: drug delivery, formulation
Read more on pmc.ncbi.nlm.nih.gov